QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.107.120758v1 324/3/883    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Sauve, A. A. PubMed PubMed Citation Articles by Sauve, A. A.

PERSPECTIVES IN PHARMACOLOGY

NAD⁺ and Vitamin B₃: From Metabolism to Therapies

Department of Pharmacology, Weill Medical College of Cornell University, New York, New York

The role of NAD⁺ metabolism in health and disease is of increased interest as the use of niacin (nicotinic acid) has emerged as a major therapy for treatment of hyperlipidemias and with the recognition that nicotinamide can protect tissues and NAD⁺ metabolism in a variety of disease states, including ischemia/reperfusion. In addition, a growing body of evidence supports the view that NAD⁺ metabolism regulates important biological effects, including lifespan. NAD⁺ exerts potent effects through the poly(ADP-ribose) polymerases, mono-ADP-ribosyltransferases, and the recently characterized sirtuin enzymes. These enzymes catalyze protein modifications, such as ADP-ribosylation and deacetylation, leading to changes in protein function. These enzymes regulate apoptosis, DNA repair, stress resistance, metabolism, and endocrine signaling, suggesting that these enzymes and/or NAD⁺ metabolism could be targeted for therapeutic benefit. This review considers current knowledge of NAD⁺ metabolism in humans and microbes, including new insights into mechanisms that regulate NAD⁺ biosynthetic pathways, current use of nicotinamide and nicotinic acid as pharmacological agents, and opportunities for drug design that are directed at modulation of NAD⁺ biosynthesis for treatment of human disorders and infections.

Address correspondence to: Anthony A. Sauve, Department of Pharmacology, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021. E-mail: aas2004{at}med.cornell.edu